Galectin‐3 Is Associated With Stage B Metabolic Heart Disease and Pulmonary Hypertension in Young Obese Patients
Deepa M. Gopal(Boston University), Wilson S. Colucci(Boston University), Caroline M. Apovian(Boston Medical Center), Chang‐seng Liang(Neusoft (China)), Courtney Donohue(Brigham and Women's Hospital), Deborah A. Siwik(Boston University), Nir Ayalon(Boston University), Vanessa Silva(University of Lisbon), Jill Downing(Boston University), Aaron L. Sverdlov(Hunter New England Local Health District), Yi‐Chih Wang(Brigham and Women's Hospital), Noyan Gokce(Boston University), Marcello Panagia(Boston University), Vijaya B. Kolachalama(Boston University), Alejandro Perez(Boston University), Jennifer E. Ho(Massachusetts General Hospital)
Cited by 22
Related Papers
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
|Journal of the American College of Cardiology|2013|4k
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
|Circulation|2013|2.7k
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
|Circulation|2023|1.7k
Targeted Anticytokine Therapy in Patients With Chronic Heart Failure
|Circulation|2004|1.2k